Ignite Creation Date:
2025-12-24 @ 12:55 PM
Ignite Modification Date:
2026-02-23 @ 8:06 PM
Study NCT ID:
NCT05883761
Status:
COMPLETED
Last Update Posted:
2024-04-04
First Post:
2023-05-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Birth Outcomes In Eswatini After Transition To Dolutegravir-Based Treatment
Sponsor:
Elizabeth Glaser Pediatric AIDS Foundation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-30
Completion Date Type:
ACTUAL
First Submit Date:
2023-05-22
First Submit QC Date:
None
Study First Post Date:
2023-06-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-03
Last Update Post Date:
2024-04-04
Last Update Post Date Type:
ACTUAL